2407 — Gaush Meditech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$797.12m
- HK$846.27m
- CNY1.43bn
- 67
- 96
- 14
- 66
Annual cashflow statement for Gaush Meditech, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 149 | -138 | -275 | 248 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 41.9 | 420 | 541 | 39.4 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -73.4 | -177 | -97.3 | -114 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 130 | 164 | 234 | 249 | — |
| Capital Expenditures | -1.82 | -28 | -48 | -45.6 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -996 | 108 | -88 | -122 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -998 | 79.8 | -136 | -168 | — |
| Financing Cash Flow Items | -2.17 | -86.7 | -42.5 | -46.3 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 856 | 72.8 | 3.08 | -190 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -25.3 | 302 | 113 | -103 | — |